Comparison UroGen Pharma (URGN) with Competitors
UroGen Pharma (URGN) industry is Biotechnology.
Profit Margin
URGN-46.26%
Industry-0.77%
Upside-45.49%
Operating Margin
URGN-39.76%
Industry-2055.25%
Upside+2015.49%
Debt-to-Equity
URGN-152.54%
Industry28.27%
Upside-180.80%
Free Cash Flow Yield
URGN-8.56%
Industry-1.75%
Upside-6.82%
P/E
URGN-14.10
Industry-20.52
Upside+641.91%
P/S
URGN13.37
Industry10.01
Upside+33.52%
P/B
URGN19.27
Industry5.15
Upside+274.41%